Amro A. Albanna - 04 Jun 2021 Form 4 Insider Report for Aditx Therapeutics, Inc. (ADTX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Amro Albanna
Issuer symbol
ADTX
Transactions as of
04 Jun 2021
Net transactions value
$0
Form type
4
Filing time
08 Jun 2021, 16:06:38 UTC
Previous filing
02 Jun 2021
Next filing
21 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADTX Common Stock Award $0 +75,000 +10% $0.000000 826,620 04 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted common stock vests in three (3) successive equal annual installments, which began on March 31, 2021.